0.00Open0.10Pre Close0 Volume69 Open Interest95.00Strike Price0.00Turnover3455.65%IV19.25%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.0357Delta0.0108Gamma797.50Leverage Ratio-106.3194Theta0.0000Rho28.44Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet